Neosaxitoxin, a Paralytic Shellfish Poison phycotoxin, blocks pain and inflammation in equine osteoarthritis.

The research conducted studies the effects of Neosaxitoxin (a phycotoxin found in Paralytic Shellfish Poison) on equine osteoarthritis, finding that it effectively blocks pain for an extended period and decreases pro-inflammatory markers, thereby improving the horse’s wellbeing.

Understanding Osteoarthritis and Neosaxitoxin

• Osteoarthritis is a chronic ailment that results in the progressive damage of the joint cartilage. This degeneration triggers significant inflammatory reactions and chronic pain in the sufferers.
• While this disease is most commonly diagnosed in humans, horses are also susceptible to osteoarthritis. As the disease presents and progresses similarly in both humans and horses, the researchers developed a study model using horses.
• Neosaxitoxin is a phycotoxin from Paralytic Shellfish Poison. In this study, the effectiveness of Neosaxitoxin as an alleviator of equine osteoarthritis symptoms was evaluated.

The Application and Effect of Neosaxitoxin

• The researchers observed the symptoms of osteoarthritis in horses, such as pain (manifested as lameness) and inflammation. They measured the levels of pro-inflammatory markers like cellular infiltration, TNF-alpha, and nitric oxide in the synovial fluid drawn from the horse’s affected joint. These markers indicate the degree of inflammation present in the osteoarthritic joint.
• Neosaxitoxin demonstrated a lasting analgesic effect, blocking pain for an average duration of 24.7 days. Moreover, its application lead to a decrease in the pro-inflammatory markers within the synovial fluid, pointing towards a reduction in inflammation.
• These effects not only relieved pain but also improved the overall welfare of the horses affected by osteoarthritis.

Significance and Potential Applications of the Findings

• The significant pain-blocking efficacy of Neosaxitoxin, along with its ability to reduce inflammatory markers, suggests that it could become a valuable tool in the development of treatment protocols for osteoarthritis.
• As the progression and activation of osteoarthritis in humans and horses are comparable, these findings may have significant future implications on the treatment of osteoarthritis in human medicine as well.
• Moreover, as Neosaxitoxin has been proven to be safe for use in the treatment of equine osteoarthritis, it further reinforces its potential as a candidate for treating osteoarthritis.